ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!LUNG Company Profile and Key Details
Pulmonx Corporation
LUNG Stock Price Chart
Stock Price Today
Pulmonx Corporation (LUNG) stock surged +0.11%, trading at $8.79 on NASDAQ, up from the previous close of $8.78. The stock opened at $7.60, fluctuating between $8.64 and $9.31 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Company Information
| Employees | 279 |
| Beta | 0.64 |
| Sales or Revenue | $68.68M |
| 5Y Sales Change% | 0.872% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Devices |
Frequently Asked Questions
Pulmonx Corporation (NASDAQ: LUNG) stock price is $8.79 in the last trading session. During the trading session, LUNG stock reached the peak price of $9.31 while $8.64 was the lowest point it dropped to. The percentage change in LUNG stock occurred in the recent session was 0.11% while the dollar amount for the price change in LUNG stock was $0.01.
The NASDAQ listed LUNG is part of Medical - Devices industry that operates in the broader Healthcare sector. Pulmonx Corporation designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. David A. Lehman
Gen. Counsel & Sec.
Ms. Lisa Paul
Chief People Officer
Mr. Sri Radhakrishnan
Chief Technical Officer
Mr. Geoffrey Beran Rose
Chief Commercial Officer
Ms. Marcee M. Maroney
Vice President of Marketing
Mr. Jérôme Erath
Senior Vice President & GM of Europe Middle-East & Africa
Sarah Huber
Vice President of Sales (U.S.)
Dr. Derrick Sung Ph.D.
Chief Financial Officer
Ms. Lauren Cristina
Vice President of Fin. & Admin. (U.S.)
Mr. Glendon E. French
Chief Executive Officer, Pres & Director
LUNG's closing price is 60.81% higher than its 52-week low of $5.46 where as its distance from 52-week high of $11.73 is -38.17%.
Number of LUNG employees currently stands at 279.
Official Website of LUNG is: https://pulmonx.com
LUNG could be contacted at phone 650 364 0400 and can also be accessed through its website. LUNG operates from 700 Chesapeake Drive, Redwood City, CA 94063, United States.
LUNG stock volume for the day was 495.04K shares. The average number of LUNG shares traded daily for last 3 months was 275.66K.
The market value of LUNG currently stands at $347.10M with its latest stock price at $8.79 and 39.49M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com